Biologics Battle Over Billions of Dollars

Fight Fueled by FTC Report That Says 12-Year Exclusivity Unnecessary

By Kate Ackley
Roll Call Staff
June 15, 2009, 12 a.m.

Lobbyists who want Congress to approve a swift pathway to generic versions of biotech drugs say the Federal Trade Commission last week handed their side a boost just as Congress wades into the health care reform debate.



Forget your password? Click here or
Call 202-824-6800

Chun: Cyber Attacks Demand Strong Public-Private Response

Nov. 6, 12:35 p.m.

The federal government is increasingly taking a leadership role in improving the nation’s cybersecurity. But, with a threat that is quickly growing and more sophisticated each day, it’s clear that the government — for all of its good intentions — cannot win this battle without a robust commitment from technology companies. Read Full Article

Roll Call Video Channels

Photo Slideshows

Photo

Photos of the Day (Nov. 5)

Photo

Photos of the Day (Nov. 4)

Photo

Photos of the Day (Nov. 3)

Photo

Photos of the Day (Nov. 2)

Photo

Photos of the Day (Oct. 29)

Photo

The Longest Yard